Acute graft-versus-host disease (GVHD) is one of the major complications of hematopoietic
stem cell transplantation. Many variables including stem cell source, age of donor and …

Acute graft-versus-host disease (GVHD) continues to be a major cause of morbidity and
mortality after allogeneic hematopoietic cell transplant (HCT) in pediatric patients (ie …

Graft-versus-host disease (GvHD) remains a significant hurdle in overcoming the morbidity
and mortality associated with haemopoietic stem cell transplantation in children. Better …

The most significant immunologic barrier to successful hematopoietic stem cell
transplantation (HSCT) is acute graft-versus-host disease (aGVHD), which can result in …

Allogeneic hematopoietic SCT (HSCT) is an established treatment for some children with life-
threatening hematological disease, immune deficiencies and inborn errors of metabolism …

Acute graft‐versus‐host disease (GvHD) is a frequent complication of allogeneic
haemopoietic stem cell transplantation (HSCT) and donor lymphocyte infusions (DLI). Its …

Chronic graft-versus-host disease (cGVHD) and late acute graft-versus-host disease (L-
aGVHD) are understudied complications of allogeneic hematopoietic stem cell …

Chronic graft-versus-host disease (cGVHD) remains the major cause of late morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). However, only a …

Pediatric allogeneic hematopoietic cell transplantation (HCT) practices differ from those of
adults, particularly the heterogeneity of transplantable nonmalignant diseases and the lower …

Current knowledge of risk factors for graft-versus-host disease (GVHD) in pediatric bone
marrow transplantation is derived from studies focusing primarily on adults. We reviewed …